Our findings identify HIF-1α as a central hub gene that links T2DM and liver injury, with its robust binding interaction with Pue positioning HIF-1α as a critical target for the therapeutic actions of Pue. The gene discussed is HIF1A; the disease is type 2 diabetes mellitus.